RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain (original) (raw)

• Selkoe, D.J. Clearing the brain's amyloid cobwebs. Neuron 32, 177–180 (2001).
  Article CAS PubMed Google Scholar
• Yan, S.D. et al. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685–691 (1996).
  Article CAS PubMed Google Scholar
• Thomas, T., Thomas, G., McLendo, C., Sutton, T. & Mullan, M. β-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380, 115–118 (1996).
  Article Google Scholar
• Shibata, M. et al. Clearance of Alzheimer's amyloid-β1–40 peptide from brain by low-density lipoprotein receptor-related protein-1 at the blood brain barrier J. Clin. Invest. 106, 1489–1499 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Zlokovic, B.V. et al. Clearance of amyloid-β-peptide from brain: transport or metabolism? Nat. Med. 6, 718–719 (2000).
  Article PubMed Google Scholar
• Bading, J.R. et al. Brain clearance of Alzheimer's amyloid-β40 in the squirrel monkey: a SPECT study in a primate model of cerebral amyloid angiopathy. J. Drug Targeting 10, 359–368 (2002).
  Article CAS Google Scholar
• DeMattos, R.B. et al. Brain to plasma amyloid-β efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295, 2264–2267 (2002).
  Article CAS PubMed Google Scholar
• DeMattos, R.B. et al. Plaque-associated disruption of CSF and plasma amyloid-β equilibrium in a mouse model of Alzheimer's disease. J. Neurochem. 81, 229–236 (2002).
  Article CAS PubMed Google Scholar
• Mackic, J.B. et al. Circulating amyloid-β peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions. Vasc. Pharmacol. 38, 303–313 (2002).
  Article CAS Google Scholar
• Zlokovic, B.V. et al. Blood-brain barrier transport of circulating Alzheimer's amyloid-β. Biochem. Biophys. Res. Commun. 197, 1034–1040 (1993).
  Article CAS PubMed Google Scholar
• Maness, L.M., Banks, W.A., Podlisny, M.B., Selkoe, D.J. & Kastin, A.J. Passage of human amyloid-β protein 1-40 across the murine blood-brain barrier. Life Sci. 55, 1643–1650 (1994).
  Article CAS PubMed Google Scholar
• Ghilardi, J.R. et al. Intra-arterial infusion of [125I]Aβ1–40 labels amyloid deposits in the aged primate brain in vivo. Neuroreport 7, 2607–2611 (1996).
  Article CAS PubMed Google Scholar
• Martel, C.L. et al. Blood-brain barrier uptake of the 40 and 42 amino acid sequences of circulating Alzheimer's amyloid-β in guinea pigs. Neurosci. Lett. 206, 157–160 (1996).
  Article CAS PubMed Google Scholar
• Zlokovic, B.V. et al. Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer's disease amyloid-β at the blood-brain and blood-cerebrospinal fluid barriers. Proc. Natl. Acad. Sci. USA 93, 4229–4236 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Martel, C.L. et al. Isoform-specific effects of apolipoproteins E2, E3, E4 on cerebral capillary sequestration and blood-brain barrier transport of circulating Alzheimer's amyloid β. J. Neurochem. 69, 1995–2004 (1997).
  Article CAS PubMed Google Scholar
• Mackic, J.B. et al. Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid-β peptide in aged squirrel monkey with cerebral amyloid angiopathy. J. Neurochem. 70, 210–215 (1998).
  Article CAS PubMed Google Scholar
• Poduslo, J.F., Curran, G.L., Sanyal, B. & Selkoe, D.J. Receptor-mediated transport of human amyloid-β1-40 and 1-42 at the blood-brain barrier. Neurobiol. Dis. 6, 190–199 (1999)
  Article CAS PubMed Google Scholar
• Wengenack, T.M., Curran, G.L. & Poduslo, J.F. Targeting Alzheimer amyloid plaques in vivo. Nat. Biotech. 18, 868–872 (2000).
  Article CAS Google Scholar
• Ghersi-Egea, J.F. et al. Fate of cerebrospinal fluid-borne amyloid β-peptide: rapid clearance into blood and appreciable accumulation by cerebral arteries. J. Neurochem. 67, 880–883 (1996).
  Article CAS PubMed Google Scholar
• Monro, O.R. et al. Substitution at codon 22 reduces clearance of Alzheimer's amyloid-β peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood. Neurobiol. Aging 23, 405–412 (2002).
  Article CAS PubMed Google Scholar
• Sigurdsson, E.M. et al. Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice. Am. J. Pathol. 159, 439–447 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Matsuoka, Y. et al. Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to β-amyloid. J. Neurosci. 23, 29–33 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Carro, E. et al. Serum insulin-like growth factor I regulates brain amyloid-β levels. Nat. Med. 8, 1390–1397 (2002).
  Article CAS PubMed Google Scholar
• Hofmann, M.A. et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 97, 889–901 (1999).
  Article CAS PubMed Google Scholar
• Yan, S.D. et al. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis. Nat. Med. 6, 643–651 (2000).
  Article CAS PubMed Google Scholar
• Mackic, J.B. et al. Human blood-brain barrier receptors for Alzheimer's amyloid-β 1-40: asymmetrical binding, endocytosis and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J. Clin. Invest. 102, 734–743 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Kawarabayashi, T. et al. Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21, 372–381 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• DeMattos, R.B. et al. Potential role of endogenous and exogenous Aβ binding molecules in Aβ clearance and metabolism. in Aβ Metabolism in Alzheimer's Disease (ed. Saido, T.) 123–139 (Landes Bioscience, Georgetown, Texas, 2003).
  Google Scholar
• Hsiao, K. et al. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science 274, 99–102 (1996).
  Article CAS PubMed Google Scholar
• Hsia, A. et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA 96, 3228–3233 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Sakaguchi, T. et al. Central role for RAGE-dependent neointimal expansion in arterial stenosis. J. Clin. Invest. 111, 959–972 (2003)
  Article CAS PubMed PubMed Central Google Scholar
• Wyss-Coray, T. et al. TGF-β-1 promotes microglial amyloid clearance and reduces plaque burden in transgenic mice. Nat. Med. 7, 612–618 (2001).
  Article CAS PubMed Google Scholar
• Helme, R., Chen, H. & Khalil Z. Mechanisms underlying the vascular activity of Aβ(25-35) at the level of skin microvasculature. Brain Res. 736, 206–216 (1996).
  Article PubMed Google Scholar
• Holtzman, D. et al. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann. Neurol. 47, 739–747 (2000).
  Article CAS PubMed Google Scholar
• Iadecola, C. et al. SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein. Nat. Neurosci. 2, 157–161 (1999).
  Article CAS PubMed Google Scholar
• Takashi R.J. et al. Intraneuronal Alzheimer's Aβ42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Pathol. 161, 1869–1879 (2002).
  Article Google Scholar
• Paris, D. et al. Soluble β-amyloid peptide mediate vasoactivity via activation of a pro-inflammatory pathway. Neurobiol. Aging 21, 183–197 (2000).
  Article CAS PubMed Google Scholar
• Niwa, K. et al. Aβ1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc. Natl. Acad. Sci. USA 97, 9735–9740 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Estrada, C., Gomez, C. & Martin, C. Effects of TNF-α on the production of vasoactive substances by cerebral endothelial and smooth muscle cells in culture. J. Cereb. Blood Flow Metab. 15, 920–928 (1995).
  Article CAS PubMed Google Scholar
• Tureen J. Effect of recombinant human tumor necrosis factor α on cerebral oxygen uptake, cerebrospinal fluid lactate, and cerebral blood flow in the rabbit: role of nitric oxide. J. Clin. Invest. 95, 1086–1091 (1995).
  Article CAS PubMed PubMed Central Google Scholar
• Quehenberger P. et al. Endothelin 1 transcription is controlled by nuclear factor-kappaB in AGE-stimulated cultured endothelial cells. Diabetes 49, 1561–1570 (2000).
  Article CAS PubMed Google Scholar
• Wautier, J-L. et al. Advanced glycation endproducts (AGEs) on the surface of diabetic red cells bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface associated AGEs and diabetic complications. Proc. Natl. Acad. Sci. USA 91, 7742–7746 (1994).
  Article CAS PubMed PubMed Central Google Scholar
• Wautier, J-L. et al. Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy: soluble receptor for advanced glycation endproducts blocks hyperpermeability. J. Clin. Invest. 97, 238–243 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Niwa, K., Kazama, K., Younkin, S.G., Carlson, G.A. & Iadecola, C. Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol. Dis. 9, 61–68 (2002).
  Article CAS PubMed Google Scholar
• Maeda, K., Mies, G., Olah, L. & Hossmann, K.-A. Quantitative measurement of local cerebral blood flow in the anesthetized mouse using intraperitoneal [14C]iodontipyrine injection and final arterial heart blood sampling. J. Cereb. Blood Flow Metab. 20, 10–14 (2000).
  Article CAS PubMed Google Scholar